Scholars Central

Conference abstractPublished 20 Mar 2017

Distinct effect of interleukin 4 and B-cell activating factor in connective tissue diseases with lung involvement and idiopathic pulmonary fibrosis

Authors: Martina Sterclova

Thomayer Hospital, Czech Republic

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: In patients with connective tissue diseases (CTDs) lung involvement may a play important prognostic role. Possible radiologic pattern of lung involvement includes usual interstitial pneumonia, typical also for idiopathic pulmonary fibrosis (IPF). We hypothesize that despite the same radiologic pattern the pathogenetic pathways in IPF and CTD may differ. Methodology & Theoretical Orientation: Sixteen naive CTD patients with lung involvement according to high resolution tomography of the chest and 17 IPF patients were included and underwent serum Ig concentration assessment, flow cytometry of peripheral blood and bronchoscopy with bronchoalveolar lavage (BAL). BAL fluid (BALF) differential cell counts and measurement of IL-4R and BAFF in BALF supernatant were performed. Findings: CTD patients exhibited higher BALF lymphocyte counts (p<0.05) and lower IL-4R concentrations (p<0.05). BAFF concentrations did not significantly differ between groups. Peripheral blood lymphocyte and CD19 counts were higher in IPF patients (p<0.05). Autoantibodies were positive in all CTD and in 8 IPF patients. BAFF concentrations positively correlated with IgM serum concentrations (both in CTD and IPF patients, (p<0.05)). Positive correlations among IL-4R concentrations, serum IgG, IgA and IgM concentrations and CD19 peripheral blood counts (p<0.05) were observed in both groups. Correlations between BAFF and IL-4R BALF concentrations were positive in CTD (p<0.01) and negative in IPF patients (p<0.05). Conclusion & Significance: Our data suggest that the immunologic and molecular markers in peripheral blood and BALF may differ in IPF and CTD patients. We hypothesize that anti-apoptotic effect of IL-4 on B cells may be clinically relevant in IPF patients, while different regulatory pathway may play role in CTD.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Immunome Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunome Research
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Martina Sterclova”